Delivery Order SPE2DB22D3016-SPE2DB25FBKD6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,833.82. The contract, awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100 count) with a ceiling value of $1,990.20. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is scheduled for completion by September 15, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,067.34. This competitive award, effective September 19, 2025, with an ultimate completion date of September 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a firm fixed price ceiling value of $1,891.02. The award, made on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location and continues...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,670.98. This firm fixed-price delivery order, which is due for completion by September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $2,308.08 delivery order contract to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 18, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,245.55 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) under a firm fixed-price contract type. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $1,997.24 delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count units) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $1,680.33. This competitively awarded, firm fixed price delivery order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a continuation of the vendor's established pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKD6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) under a firm fixed-price contract valued at $2,682.60. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of September 22, 2025, just three days following the award date of September 19, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an approximately $1 billion pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal military and veteran healthcare systems, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's existing federal contract portfolio demonstrates substantial experience fulfilling diverse medical procurement requirements through competitive awards, positioning it to efficiently deliver critical pharmaceutical commodities to support Defense Health Agency operations and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/19/25 |